Difference between revisions of "Murakami S, et al. Stem Cells (2015) cited as Ref 76 in DOI: 10.1038/s41392-020-0110-5 (Q9339)"
Jump to navigation
Jump to search
(Created claim: DOI Identifier (P138): 10.1002/stem.2059, #quickstatements; #temporary_batch_1590000649558) |
(Created claim: Page(s) (P105): 2652-2663, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (5 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 26013162 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2015
| ||||||||||||||
| Property / Publication Date: 2015 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Stem Cells | ||||||||||||||
| Property / Published In Name String: Stem Cells / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 33 | ||||||||||||||
| Property / Volume: 33 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | SRY and OCT4 are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets (English) | ||||||||||||||
| Property / title: SRY and OCT4 are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 2652-2663 | ||||||||||||||
| Property / Page(s): 2652-2663 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:29, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Murakami S, et al. Stem Cells (2015) cited as Ref 76 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Murakami S
0 references
2015
0 references
Stem Cells
0 references
33
0 references
SRY and OCT4 are required for the acquisition of cancer stem cell-like properties and are potential differentiation therapy targets (English)
0 references
2652-2663
0 references
